Protagonist Therapeutics (PTGX) Asset Utilization Ratio (2018 - 2026)

Protagonist Therapeutics has disclosed Asset Utilization Ratio across 9 years of filings, most recently posting 0.11 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.11, down 60.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.11 (down 60.11% YoY), and the FY2025 annual result was 0.07, down 91.73% from the prior year.
• Asset Utilization Ratio came in at 0.11 for Q1 2026 at Protagonist Therapeutics, up from 0.07 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.64 in Q4 2024 to a low of 0.0 in Q2 2023.
• The 5-year median for Asset Utilization Ratio is 0.13 (2022), against an average of 0.21.
• Across the five-year window, Asset Utilization Ratio sank 100.05% in 2023 and soared 769383.91% in 2024, its largest moves.
• Protagonist Therapeutics' Asset Utilization Ratio stood at 0.1 in 2022, then plunged by 70.99% to 0.03 in 2023, then jumped by 2087.46% to 0.64 in 2024, then plunged by 89.44% to 0.07 in 2025, then soared by 61.45% to 0.11 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.11 (Q1 2026), 0.07 (Q4 2025), and 0.29 (Q3 2025), per Business Quant data.